Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis

Simsek, Melek
Lissenberg-Witte, Birgit I.
Riswijk, Milou L.M. van
Verschuren, Sander
Hoentjen, F.
Oldenburg, B.
Dijkstra, Gerard
Boer, N.K. de

Publication date

January 2019

DOI

10.1111/apt.15229

Publisher

Wiley

Language

English

Abstract

Contains fulltext : 204038.pdf (publisher's version ) (Open Access

Extracted data

Related items

Treatment of Refractory Crohn’s Disease and Pyoderma Gangrenosum with a Combination Regimen of

Rifaximin Gentamicin
Neil D. Goldberga
Aravinda Vadlamudib
Nicole Parrishb

August 2016

www.karger.com/crg This is an Open Access article licensed under the terms of the Creative Commons A...

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

Biancone, Livia
Annese, Vito
Ardizzone, Sandro
Armuzzi, Alessandro
Calabrese, Emma
Caprioli, Flavio
Castiglione, Fabiana
Comberlato, Michele
Cottone, Mario
Danese, Silvio
Daperno, Marco
D'Incà, Renata
Frieri, Giuseppe
Fries, Walter
Gionchetti, Paolo
Kohn, Anna
Latella, Giovanni
Milla, Monica
Orlando, Ambrogio
Papi, Claudio
Petruzziello, Carmelina
Riegler, Gabriele
Rizzello, Fernando
Saibeni, Simone
Scribano, Maria Lia
Vecchi, Maurizio
Vernia, Piero
Meucci, Gianmichele

April 2017

Inflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence ...

Safety of treatments for inflammatory bowel disease : clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

L. Biancone
V. Annese
S. Ardizzone
A. Armuzzi
E. Calabrese
F. Caprioli
F. Castiglione
M. Comberlato
M. Cottone
S. Danese
M. Daperno
R. D&apos
G. Frieri
W. Fries
P. Gionchetti
A. Kohn
G. Latella
M. Milla
A. Orlando
C. Papi
C. Petruzziello
G. Riegler
F. Rizzello
S. Saibeni
M.L. Scribano
M. Vecchi
P. Vernia
G. Meucci

April 2017

Inflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence ...

Off-label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis

the Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC)

May 2019

Background: Off-label prescribing is encountered across various fields of medicine and creates alter...

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis

May 2019

BACKGROUND: Off-label prescribing is encountered across various fields of medicine and creates alter...

Medical treatment of chronic inflammatory bowel diseases: clinical and pharmacokinetic aspects, with emphasis on 5-aminosalicylic acid delivering drugs

Rijk, M.C.M.

January 1991

Contains fulltext : mmubn000001_118419005.pdf (publisher's version ) (Open Access)...

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates

Hugh James Freeman

August 2016

This is an open access article. Unrestricted non-commercial use is permitted provided the original w...

Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.

Verhagen, C.C.
Niezink, A.G.H.
Engels, Y.M.P.
Hekster, Y.A.
Doornebal, J.J.
Vissers, K.C.P.

January 2008

Contains fulltext : 71297.pdf (publisher's version ) (Closed access)Off-label medi...

Abatacept for Crohn's disease and ulcerative colitis

Sandborn, William J
Colombel, Jean-Frederic
Sands, Bruce E
Rutgeerts, Paul
Targan, Stephan R
Panaccione, Remo
Bressler, Brian
Geboes, Karl
Schreiber, Stefan
Aranda, Richard
Gujrathi, Sheila
Luo, Allison
Peng, Yun
Salter-Cid, Luisa
Hanauer, Stephen B

July 2012

The efficacy of abatacept, a selective costimulation modulator, in Crohn's disease (CD) and ulcerati...

Off-label prescription : practice and problems

Carneiro, António Vaz
Costa, João

January 2013

Approval of a drug for clinical use requires production of data on efficacy and safety through submi...

Novel Nonbiologic Therapies for Ulcerative Colitis

Juillerat, Pascal
Korzenik., JR

January 2014

An extensive array of compounds has been studied for the treatment of ulcerative colitis (UC). The m...

[A step-by-step guide for safe off-label prescribing]

Zanden, T.M. van der
Schrier, L.
Wildt, S.N. de

January 2021

Item does not contain fulltextThe Dutch Medicines Act and the Medical Treatment Contracts Act (WGBO)...

Corticosteroids and azathioprine in the treatment of inflammatory bowel disease

Powell-Tuck, J

January 1980

SIGLEAvailable from British Library Document Supply Centre- DSC:D36985/81 / BLDSC - British Library ...

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Biancone L
Annese V
Ardizzone S
Armuzzi A
Calabrese E
Caprioli F
Castiglione F
Comberlato M
Cottone M
Danese S
Daperno M
D'Incà R
Frieri G
Fries W
Gionchetti P
Kohn A
Latella G
Milla M
Orlando A
Papi C
Petruzziello C
Riegler G
Rizzello F
Saibeni S
Scribano ML
Vecchi M
Vernia P
Meucci G
Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Ricci C.

January 2017

nflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence a...

Topical opioids for painful ulcers in systemic sclerosis.

Ingen, I.L. van
Jansen, M.M.
Barrera, P.

January 2008

Contains fulltext : 70616.pdf (publisher's version ) (Closed access

Treatment of Refractory Crohn’s Disease and Pyoderma Gangrenosum with a Combination Regimen of

Rifaximin Gentamicin
Neil D. Goldberga
Aravinda Vadlamudib
Nicole Parrishb

August 2016

www.karger.com/crg This is an Open Access article licensed under the terms of the Creative Commons A...

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

Biancone, Livia
Annese, Vito
Ardizzone, Sandro
Armuzzi, Alessandro
Calabrese, Emma
Caprioli, Flavio
Castiglione, Fabiana
Comberlato, Michele
Cottone, Mario
Danese, Silvio
Daperno, Marco
D'Incà, Renata
Frieri, Giuseppe
Fries, Walter
Gionchetti, Paolo
Kohn, Anna
Latella, Giovanni
Milla, Monica
Orlando, Ambrogio
Papi, Claudio
Petruzziello, Carmelina
Riegler, Gabriele
Rizzello, Fernando
Saibeni, Simone
Scribano, Maria Lia
Vecchi, Maurizio
Vernia, Piero
Meucci, Gianmichele

April 2017

Inflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence ...

Safety of treatments for inflammatory bowel disease : clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

L. Biancone
V. Annese
S. Ardizzone
A. Armuzzi
E. Calabrese
F. Caprioli
F. Castiglione
M. Comberlato
M. Cottone
S. Danese
M. Daperno
R. D&apos
G. Frieri
W. Fries
P. Gionchetti
A. Kohn
G. Latella
M. Milla
A. Orlando
C. Papi
C. Petruzziello
G. Riegler
F. Rizzello
S. Saibeni
M.L. Scribano
M. Vecchi
P. Vernia
G. Meucci

April 2017

Inflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence ...

Off-label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis

the Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC)

May 2019

Background: Off-label prescribing is encountered across various fields of medicine and creates alter...

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis

May 2019

BACKGROUND: Off-label prescribing is encountered across various fields of medicine and creates alter...

Medical treatment of chronic inflammatory bowel diseases: clinical and pharmacokinetic aspects, with emphasis on 5-aminosalicylic acid delivering drugs

Rijk, M.C.M.

January 1991

Contains fulltext : mmubn000001_118419005.pdf (publisher's version ) (Open Access)...

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates

Hugh James Freeman

August 2016

This is an open access article. Unrestricted non-commercial use is permitted provided the original w...

Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.

Verhagen, C.C.
Niezink, A.G.H.
Engels, Y.M.P.
Hekster, Y.A.
Doornebal, J.J.
Vissers, K.C.P.

January 2008

Contains fulltext : 71297.pdf (publisher's version ) (Closed access)Off-label medi...

Abatacept for Crohn's disease and ulcerative colitis

Sandborn, William J
Colombel, Jean-Frederic
Sands, Bruce E
Rutgeerts, Paul
Targan, Stephan R
Panaccione, Remo
Bressler, Brian
Geboes, Karl
Schreiber, Stefan
Aranda, Richard
Gujrathi, Sheila
Luo, Allison
Peng, Yun
Salter-Cid, Luisa
Hanauer, Stephen B

July 2012

The efficacy of abatacept, a selective costimulation modulator, in Crohn's disease (CD) and ulcerati...

Off-label prescription : practice and problems

Carneiro, António Vaz
Costa, João

January 2013

Approval of a drug for clinical use requires production of data on efficacy and safety through submi...

Novel Nonbiologic Therapies for Ulcerative Colitis

Juillerat, Pascal
Korzenik., JR

January 2014

An extensive array of compounds has been studied for the treatment of ulcerative colitis (UC). The m...

[A step-by-step guide for safe off-label prescribing]

Zanden, T.M. van der
Schrier, L.
Wildt, S.N. de

January 2021

Item does not contain fulltextThe Dutch Medicines Act and the Medical Treatment Contracts Act (WGBO)...

Corticosteroids and azathioprine in the treatment of inflammatory bowel disease

Powell-Tuck, J

January 1980

SIGLEAvailable from British Library Document Supply Centre- DSC:D36985/81 / BLDSC - British Library ...

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Biancone L
Annese V
Ardizzone S
Armuzzi A
Calabrese E
Caprioli F
Castiglione F
Comberlato M
Cottone M
Danese S
Daperno M
D'Incà R
Frieri G
Fries W
Gionchetti P
Kohn A
Latella G
Milla M
Orlando A
Papi C
Petruzziello C
Riegler G
Rizzello F
Saibeni S
Scribano ML
Vecchi M
Vernia P
Meucci G
Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Ricci C.

January 2017

nflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence a...

Topical opioids for painful ulcers in systemic sclerosis.

Ingen, I.L. van
Jansen, M.M.
Barrera, P.

January 2008

Contains fulltext : 70616.pdf (publisher's version ) (Closed access

Treatment of Refractory Crohn’s Disease and Pyoderma Gangrenosum with a Combination Regimen of

Rifaximin Gentamicin
Neil D. Goldberga
Aravinda Vadlamudib
Nicole Parrishb

August 2016

www.karger.com/crg This is an Open Access article licensed under the terms of the Creative Commons A...

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

Biancone, Livia
Annese, Vito
Ardizzone, Sandro
Armuzzi, Alessandro
Calabrese, Emma
Caprioli, Flavio
Castiglione, Fabiana
Comberlato, Michele
Cottone, Mario
Danese, Silvio
Daperno, Marco
D'Incà, Renata
Frieri, Giuseppe
Fries, Walter
Gionchetti, Paolo
Kohn, Anna
Latella, Giovanni
Milla, Monica
Orlando, Ambrogio
Papi, Claudio
Petruzziello, Carmelina
Riegler, Gabriele
Rizzello, Fernando
Saibeni, Simone
Scribano, Maria Lia
Vecchi, Maurizio
Vernia, Piero
Meucci, Gianmichele

April 2017

Inflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence ...

Safety of treatments for inflammatory bowel disease : clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

L. Biancone
V. Annese
S. Ardizzone
A. Armuzzi
E. Calabrese
F. Caprioli
F. Castiglione
M. Comberlato
M. Cottone
S. Danese
M. Daperno
R. D&apos
G. Frieri
W. Fries
P. Gionchetti
A. Kohn
G. Latella
M. Milla
A. Orlando
C. Papi
C. Petruzziello
G. Riegler
F. Rizzello
S. Saibeni
M.L. Scribano
M. Vecchi
P. Vernia
G. Meucci

April 2017

Inflammatory bowel diseases are chronic conditions of unknown etiology, showing a growing incidence ...